REQUEST A DEMO
Total
USD $0.00
Search more companies

Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Brightgene Bio-Medical Technology Co., Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) is an enterprise located in China, with the main office in Suzhou. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on October 26, 2001. It currently has a total number of 1,128 (2022) employees. The company’s latest financial report indicates a net sales revenue drop of 4.59% in 2025. There was a total growth of 13.04% in Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司)’s total assets over the same period. Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司)’s net profit margin decreased by 7.99% in 2025.

Headquarters
Building C25-C28, Nano Science and Technology Park, No. 218 Xinghu Street, Industrial Park, Suzhou City, Jiangsu Province
Suzhou; Jiangsu; Postal Code: 215123

Contact Details: Purchase the Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) report to view the information.

Website: http://www.bright-gene.com

Basic Information
Total Employees:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) report to view the information.
Registered Capital:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) report to view the information.
Financial Auditors:
Purchase the Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) report to view the information.
Incorporation Date:
October 26, 2001
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
26.87%
Purchase this report to view the information.
6.34%
Purchase this report to view the information.
5.34%
Purchase this report to view the information.
4.41%
Purchase this report to view the information.
2.76%
Subsidiaries
BRIGHTGENE EUROPE GMGH I.GR.
100%
Borui Bio-Pharmaceutical Taixing City Co., Ltd.
100%
Borui Biological (Hong Kong) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Brightgene Bio-Medical Technology Co., Ltd. (博瑞生物医药(苏州)股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-4.59%
Total Operating Revenue
-3.72%
Operating Profit
-90.85%
Net Profit/Loss for the Period
-73.84%
Total Assets
13.04%
Total Equity
17.32%
Operating Profit Margin
-11.3%
Net Profit Margin
-7.99%
Return on Equity (ROE)
-4.52%
Debt / Equity
-16524%
Quick Ratio
-99.73%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?